NHS National Framework for Transition products (Axitinib and Eltrombopag)
Estimated value
—
Awarded value
£52.4m
Suppliers
7
Lots
1
Published
30 Jul 2025
Description
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
Scope
- Reference
- C357509
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2025 to 31 Jan 2027Possible extension to 31 Jan 2029
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Price is not the only award criterion | — | price | 100.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£52.4m
Award date
15 Jul 2025
Contract start
30 Sept 2025
Contract end
31 Jan 2027